Ever increasing HIV diversity means that vaccination and ... focusing on conserved proteins or protein regions; creating cocktails of variants and tailoring vaccines to counter the virus ...

Effectively, instead of trying to introduce COVID proteins as a vaccine into the body, they induce the body to make its own vaccine. In the case of HIV, because a wider variety of HIV proteins are ...

HIV-1 Vif induces a unique and prolonged pseudo-metaphase arrest by disrupting phosphatase feedback regulation at the kinetochore.

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

This involves the HIV-1 protease (a viral enzyme), that cuts up Gag into six smaller proteins including the capsid protein and the matrix protein. This causes a huge structural rearrangement of ...

Many diagnostic tests for HIV detect the presence of antibodies to HIV in blood. When HIV is outside a cell it is known as a virion and is surrounded by a protective envelope. The envelope surrounds a ...

Algal proteins offer a sustainable, nutrient-rich alternative to traditional proteins, with benefits for food security, ...

Early steps of infection by HIV-1 involve entry of the viral core into cells, reverse transcription to form the linear viral DNA, and integration of that DNA into a chromosome of the host.

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...